Font Size: a A A
Keyword [Imatinib-mesylate]
Result: 61 - 80 | Page: 4 of 5
61. The Role Of MircroRNA In Imatinib Mesylate Resistance Of Chronic Myeloid Leukemia
62. Retrospective Clinical Study Of Nilotinib As A Second-line Therapy In Imatinib Treatment-failure Patients With Chronic Myeloid Leukemia In Chronic Phase
63. Consistency Evaluation Of Dissolution Curves Between Generic And Branded Imatinib Mesylate Tablets In Various Media
64. Efficacy And Safety Of Imatinib Mesylate For Treating Patients With Chronic Myeloid Leukemia In Chronic Phase
65. A Single-center Study Of Imatinib In The Treatment Of Chronic Myeloid Leukemia
66. Study On Adherence And Influence Factors Of Imatinib Mesylate In Patients With Gastrointestinal Stromal Tumors
67. Clinical Analysis Of 173 Cases Of Gastrointestinal Stromal Tumors
68. Synthesis Of Imatinib Mesylate
69. The Morphological Characteristics Of Telocytes In Mouse Submandibular Gland And The Effects On Salivary Secretion Function Of Submandibular Gland
70. Growth Retardation In Children With Chronic Myeloid Leukemia After Imatinib Administration:Case Report And Literature Review
71. Clinical Study Of Second-line Treatment Of Advanced Gastrointestinal Stromal Tumor With Sunitinib Malate (Analysis Of 37 Cases)
72. Analysis Of The Efficacy Of Imatinib Mesylate In The Preoperative Treatment Of High Risk Gastrointestinal Stromal Tumors
73. Clinical And Pathological Evaluation Of Preoperative Adjuvant Imatinib Therapy In GIST
74. Study On The Synergistic Inhibitory Effect Of Ionizing Radiation Combined With Imatinib Mesylate On Gastrointestinal Stromal Tumor Cells And Its Mechanism
75. Effects Of Imatinib Mesylate On Proliferation,apoptosis And Migration In Human Colorectal Cancer Cell Line SW-837
76. MiR-181a Suppresses Chronic Myeloid Leukemia Stem/progenitor Cells Via Regulation Of GATA6 And SERPINE1
77. The Role Of ZFX In Chronic Myeloid Leukemia Stem/Progenitor Cells
78. Control of imatinib mesylate drug resistance in BCR-ABL+ leukemia
79. Influences on physician recommendation for imatinib mesylate in chronic phase chronic myeloid leukemia patients
80. Efficacy,Safety And Standardized Management Of A Domestic Imatinib Mesylate In The Treatment Of Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase
  <<First  <Prev  Next>  Last>>  Jump to